Radioisotope therapy and clinical trial design: the need for consensus and innovation.
McEwan
Alexander J B
AJ
Department of Nuclear Medicine, Cross Cancer Institute, Edmonton, Alberta, Canada. sandymce@cancerboard.ab.ca
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002945:Cisplatin / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D006801:Humans; D010166:Palliative Care / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D013326:Strontium Radioisotopes / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D013326:Strontium Radioisotopes; D002945:Cisplatin